Good Kitty Review – The Headline Number Is Not What That Trial Found

Good Kitty sells UTI Biome Shield, an over-the-counter capsule aimed at women with recurrent urinary tract infections, particularly the ones that follow sex. It is $99 to start and $66.30 a month on subscription. The cranberry component is dosed correctly, the safety pages are more careful than almost anything else in this category, and the company tells you outright to take antibiotics if you already have an infection. It also displays a 93% efficacy figure credited by name to a trial that reported a non-significant 24%, and reproduces an FDA claim with the sentence FDA requires alongside it removed.

What It Is and Who It Is For

UTI Biome Shield is a single purple capsule containing a cranberry extract standardised to 38 mg of soluble A-type proanthocyanidins, 500 mg of d-mannose, and unstated amounts of vitamin D3 and zinc picolinate. The stated regimen is one capsule daily, or two taken up to an hour before sex. It is sold direct from the company website to the United States only, with no prescription and no consultation.

The target reader is specific and the company describes her accurately: someone who gets repeated infections, often after intimacy, who has been cycling through antibiotics and wants something to take between episodes. That is a real and badly served problem. Around one in eight women has three or more UTIs a year by the figures the company quotes, and the standard offer from primary care has for years been low-dose prophylactic antibiotics.

One clarification before anything else. Some affiliate listings file this product under a prescription category. It is not a prescription. It is a dietary supplement, which the company states plainly in its own FAQ, and dietary supplements are not reviewed by the FDA for safety or effectiveness before they go on sale.

Read This First

Nothing here is medical advice. Recurrent UTI has causes worth investigating, and the treatments with the strongest current evidence are things a clinician prescribes rather than things you buy online. Talk to a doctor, and if you are on a blood thinner or have a history of kidney stones, read the interaction section below before you order.

The Headline Number and What That Trial Found

The research page opens with a block called the evidence in numbers. The largest figure in it is this:

Naming the paper is good practice, and it made the claim checkable. There is exactly one cranberry paper by an author named Babar in the PubMed index, published in BMC Urology in 2021. It is a double-blind randomised controlled trial. Here is what it actually reports.

The trial did not meet its primary endpoint. The strongest number in it is a 43% reduction in a subgroup identified after the fact, which is the kind of finding researchers report as hypothesis-generating rather than as proof.

There is a real irony underneath this. The high dose Babar tested was 37 mg of PACs a day. Good Kitty delivers 38 mg. The company picked its dose from the right trial and then quoted a result that trial did not produce. This figure was also not on the site in September 2025 when the Internet Archive last captured the product page. It is a recent addition.

Four Efficacy Figures on One Site

Once we started checking, the numbers stopped agreeing with each other. All four of these are live on goodkittyco.com as of 8 August 2026, on pages that link to one another.

A reader who lands on the cranberry page is told 42%. A reader who lands on the research page is told 93% and 30% within the same block. The d-mannose figure is 76% on one page and 60% on another. These are not rounding differences. They are different claims about the same product, and at least one of them is not in the paper it is attached to.

The FDA Claim, Minus Its Second Sentence

The ingredients page carries a box headed FDA QUALIFIED HEALTH CLAIM containing this sentence:

That sentence is genuine. It comes from FDA letter of enforcement discretion on cranberry and recurrent UTI. We downloaded the letter from fda.gov and read it. The wording FDA sets out for cranberry dietary supplements is this, in full:

The second sentence is not decoration. A qualified health claim is qualified precisely because FDA did not find the evidence strong enough for an unqualified one, and the letter states that FDA intends to exercise enforcement discretion only when the claims are appropriately worded so as not to mislead consumers. Reproducing the first half under a heading that says FDA QUALIFIED HEALTH CLAIM, while deleting the half that says the evidence is limited, inverts what the regulator was doing.

There is a second problem with displaying that claim at all. FDA conditioned it on a cranberry dietary supplement containing at least 500 mg of cranberry fruit powder that is 100% fruit. Good Kitty own label declares 250 mg of a PAC-standardised extract, not 500 mg of whole cranberry fruit powder. Those are different things, and the site does not explain how the product meets the condition the claim is tied to.

The Cranberry Half Is the Real Part

Having been hard on the marketing, here is the part that holds up, and it matters more than the rest of this review put together if you are deciding whether to buy.

Dose and form are where most cranberry supplements fail, and Good Kitty gets both right. It declares 38 mg of A-type PACs verified by the DMAC method, above the roughly 36 mg daily threshold that dose-response work and recent reviews treat as the working minimum. Most cranberry capsules on a shelf are whole-fruit or juice powder delivering single-digit milligrams of PACs, and many do not state PAC content at all. The company criticism of those products is fair, and the advice on their cranberry page, that a supplement which does not list its PAC content probably does not have a clinical dose, is advice we would give a reader ourselves.

Two caveats on their own framing. First, the same Cochrane review they cite contains this sentence: no difference in the risk for UTIs could be demonstrated between low, moderate and high doses of PACs. That is the review directly declining to support the dose-superiority argument that the whole marketing rests on. Second, the site describes the extract as 100% bioavailable on one page and 100% soluble on another. Those are not synonyms. Proanthocyanidins are large, poorly absorbed molecules; solubility is a real and useful property, and using the word bioavailable for it overstates what has been measured.

The D-Mannose Half Is a Quarter of the Studied Dose

Good Kitty puts 500 mg of d-mannose in each capsule. The trials used 2 grams a day. Not roughly 2 grams, not somewhere in that range. Kranjcec 2014 used 2 g. MERIT, the 2024 trial in JAMA Internal Medicine, used 2 g.

The site addresses this directly, on the d-mannose ingredient page:

We searched for those studies. We could not find a trial comparing 500 mg with 2,000 mg of d-mannose for daily UTI prevention, and the reference list on that same page does not contain one. It cites Kranjcec at 2 g, a 2016 pilot study, a 2020 meta-analysis and a feasibility study in multiple sclerosis. None of them is a dose-equivalence trial. If such a study exists, the company should name it, because the claim is doing a lot of work: it is the justification for a dose one quarter the size of the evidence base.

Four separate meta-analyses published since have reached compatible conclusions. A 2025 review of 6 trials and 1,167 participants found no significant reduction, RR 0.57 with a confidence interval of 0.29 to 1.15. A 2025 review of 4 trials and 890 participants found RR 0.44, P equals 0.082. A 2026 review found RR 0.37 with very high heterogeneity and noted that the largest and highest-quality study showed no significant difference against placebo. The 2026 overview of 27 systematic reviews put d-mannose in the group where stronger evidence is needed.

To be scrupulously fair: Good Kitty does cite MERIT, on a general education page about chronic UTIs, where they write that it complicated the picture. It is not cited on the d-mannose ingredient page that carries the 60% figure, and it is not on the product page. The one trial that most directly undercuts one of the two headline ingredients is acknowledged in the place a buyer is least likely to be standing.

Two Citations That Had No Placebo Arm

This one is small and specific and shows up twice, which is why it is worth a section.

The d-mannose page says clinical studies show d-mannose reduces recurrent UTI incidence versus placebo, and credits Kranjcec. Kranjcec randomised women three ways: 2 g of d-mannose, 50 mg of nitrofurantoin, or no prophylaxis at all. There was no placebo group and no blinding. Knowing you have been assigned to nothing, in a trial about symptoms you self-report and act on, is exactly the situation a placebo control exists to handle.

The cranberry page says clinical studies show a 42% reduction in recurrent UTIs versus placebo, and credits Kontiokari. Kontiokari 2001 was an open randomised trial of 150 women comparing cranberry-lingonberry juice, a Lactobacillus drink, and no intervention. Also no placebo. It also studied a juice, not a PAC-standardised capsule.

The placebo-controlled evidence exists and points the other way for d-mannose. Attaching the phrase versus placebo to two open-label trials, on two different pages, is the kind of thing that would not survive a careful editor, and this company clearly employs careful editors, as the next-but-one section shows.

What the Label Does Not Tell You

The block headed Supplement Facts on the product page is not a supplement facts panel. This is the whole of it, reproduced as published:

Three of the five actives have no amount attached. The 500 mg d-mannose figure appears elsewhere on the site but not here. The vitamin D3 and zinc amounts we could not find anywhere on the site at all, and both are nutrients with established daily values and upper limits, which is exactly why a real panel declares them. If you already take a multivitamin or a separate vitamin D, you currently have no way to know what you are stacking. Ask the company before you order, or read the physical label.

A few lines below that panel, the same page has a section headed WHAT WE LEAVE OUT. It lists, among other things, no binders, fillers or anti-caking agents. The other ingredients directly above are microcrystalline cellulose, which is a binder and filler, magnesium stearate, which is a flow agent, and silicon dioxide, which is an anti-caking agent. The same list also says no sugar, and the second-largest active is d-mannose, which the company own ingredient page correctly describes as a naturally occurring sugar. None of these excipients is remotely dangerous. The problem is that the claim and the ingredient list contradict each other inside one screen.

One more inconsistency in the same family. The cranberry pages describe PACphenol as a patented double-extraction in one place and a patent-pending double-extraction process two paragraphs later. Those are legally different statements. The company legal page lists four trademark serial numbers, three of them filed in October and November 2024 with numbers in the same range, and one for the Good Kitty word mark with a number from a completely different range attached to a January 2024 filing date. Serial numbers are issued in sequence, so those two figures cannot both be right.

Product Facts

What It Costs, and What It Used to Cost

There is no volume discount. The 120 and 180-capsule options cost precisely two and three times the 60-capsule refill. Buying more saves you nothing but a reorder.

One dated change worth knowing. The Internet Archive captured the product page on 16 September 2025. At that point the product was $78, and the page read: exclusive canister and pill stash pendant free with purchase. Today the same bundle is $99, the supplement alone is $78, and the canister and pendant are described as a $149 value included free with a subscription. The accessories that were free eleven months ago now carry a $21 premium on the one-off purchase while still being marketed as free. On the live page, one of the subscription descriptions renders as canister and pill stash, total value, with the number missing entirely.

Three Refund Policies, One Product

This is the single most important practical finding in this review, because it decides what happens if the product does not work for you.

Read together, the guarantee covers the supplement portion of your first order and nothing afterwards. Every subscription refill you buy from month two onwards is, by the company own published policy, non-returnable. The amount deducted for the canister and pendant is not published, so you cannot work out what a $99 refund actually returns.

Two smaller notes on the legal pages. The subscription auto-renews indefinitely until you cancel, which you can do from the account page, and the company reserves the right to change subscription fees with prior notice. There is no forced-arbitration or class-action waiver clause, which is genuinely better than most direct-to-consumer supplement brands. And the governing law clause reads: the laws of the Country shall govern these Terms. That is an unfilled placeholder from a boilerplate template, so the governing jurisdiction is literally undefined.

Shipping, and the $60 Line

Domestic shipping is $6.99 flat, and free above a threshold. The threshold is $99 in the site announcement bar and in the product page shipping section, and $60 on the sticky add-to-cart bar at the bottom of the same page. The returns page quotes the $6.99 flat rate and does not mention a free-shipping threshold at all. Expedited delivery is $19.99 on the product page and $20.00 on the returns page.

The Clinicians Are Real. Two of Them Work There.

Supplement brands quoting doctors is usually where a review finds the worst problems, so we checked all four named clinicians against the national provider registry. Every one is a real, actively licensed practitioner, correctly described. That is a genuinely good result and we want to say so before the criticism.

The problem is not the people, it is the framing. Both internal relationships are disclosed somewhere on the site and neither is disclosed at the point of endorsement. Dr Knight appears under a heading that says what the doctors are saying and under a research-page heading that says trusted by physicians who treat UTIs every day, with no note that she helped create the product. Dr Blake appears under OUR MEDICAL ADVISORS, labelled Wellness Pioneer and Stanford, with no note that she co-founded the company. Elsewhere on the site she is quoted correctly as Good Kitty Cofounder, so the company knows how to label her.

There is one more thing worth flagging about the quotes themselves. Dr Abratowski full statement on the research page begins: for patients seeking evidence-based, non-antibiotic approaches to UTI prevention, this is the most advanced solution I have encountered in clinical practice. The pull-quote on the product page drops the opening clause and presents the rest as an unqualified superlative. That conditional was doing real work, and removing it changes what he said.

Elsewhere the site says the product is recommended by 750 clinicians on a platform called FrontrowMD. FrontrowMD is a commercial clinician-marketing service that brands pay to use, not an independent survey of practitioners, and we could not verify the count. Take it as a marketing placement rather than as a poll of the profession.

What They Get Right

A pattern emerged while we were checking this site, and it is the most interesting thing about the company. The further you get from the buy button, the better the writing gets.

The education pages are, in places, better than what most publishers produce. The chronic-UTI page cites the 2018 hydration trial, the 2023 Cochrane review, the AUA guideline and the MERIT trial by full citation, and tells the reader that if they do nothing else on the list, drink more water — advice that sells nothing. The ingredients page answers the two safety questions that matter for cranberry, and answers them well:

Other things we credit. Telling people with an active UTI to take antibiotics, on the product page, where it costs them a sale. Advising a two-hour gap between the capsule and an antibiotic course. Saying plainly that no prescription is needed. Naming DMAC verification and publishing a PAC number at all, which most of the shelf does not. Choosing a dose that matches the research rather than one that fits a price point. Pledging 1% of sales to named organisations. And having no forced arbitration clause.

That is why the failures read as choices. A company that can write a quantified oxalate explanation knows the difference between 24% and 93%, and knows what the second sentence of an FDA qualified health claim is for.

One regression we can date. In September 2025 the warfarin warning and the oxalate explanation were on the product page. Today they are only on a separate ingredients page, two clicks away. The safety content did not get worse. It moved off the page where people buy.

How It Compares

The honest summary of that table is that the two interventions with the strongest current support are things a clinician prescribes, the free one is water, and the supplement category contributes one ingredient worth taking. Good Kitty contains that ingredient at the right dose. It also charges a premium for a second ingredient the evidence has moved against.

Who Should Consider It, and Who Should Not

Reasonable fit:

• You get post-sex UTIs, you want a PAC dose that matches the research, and you value taking one capsule over measuring powder
• You have tried supermarket cranberry capsules and got nothing, which is unsurprising given most deliver single-digit milligrams of PACs
• You have already had the conversation with a clinician about prescription options and want something alongside
• You can absorb roughly $800 a year, or about $400 if you set a 60-day delivery cadence

Look elsewhere if:

• You have symptoms now. That needs a clinician and probably antibiotics, today
• You are postmenopausal and have not yet discussed vaginal oestrogen, which has stronger evidence in that group than anything in this capsule
• Cost matters. A standalone DMAC-verified PAC supplement delivers the evidence-backed component for a fraction of this
• You are buying mainly for the d-mannose. It is at a quarter of the studied dose, and the studied dose failed against placebo in the largest trial
• You take warfarin or another non-vitamin-K blood thinner, or have a stone history, and have not cleared it with your prescriber
• You are pregnant or nursing and have not asked your obstetric clinician
• You are in Alaska, Hawaii, Puerto Rico or Guam, where the $60 shipping charge changes the economics entirely

Pros and Cons

Limitations of This Review

Everything above was checked on 8 August 2026 against the company own published pages, its Shopify product data, its policy pages, an archived capture of its product page from 16 September 2025, the FDA letter of enforcement discretion on cranberry downloaded from fda.gov, the national provider registry, and the primary literature on PubMed. Prices and policies change; re-check before ordering.

We have not taken the product and we have not tested a capsule. Ingredient amounts are as published by the company, and where they publish nothing we have said so rather than estimating. We could not read the physical label, so the vitamin D3 and zinc amounts may well be declared there; our criticism is that they are not on the website. We could not independently verify the patent or trademark filings because the USPTO status interface now requires a registered key, so the serial numbers quoted here are the company own published figures.

For independent sentiment: there is no Better Business Bureau profile for Good Kitty Wellness Corporation, which we confirmed by running a control search that returned results normally. We found no Trustpilot page, live or archived. The customer reviews we could read are the ones hosted on the company own site, where the star rating shows as 4.9 from 81 reviews in the page header and 4.9 from 73 in the review widget below it, and where a set of unlabelled testimonials sits above the genuinely verified-buyer ones. In September 2025 the same widget showed 5.0 from 22. That is a first-party, brand-solicited review base, which reads high by construction.

The company also publishes a before-and-after microbiome panel attributed to June Bio Laboratories, showing Lactobacillus crispatus rising to 60.3% and vaginal E. coli falling to zero. No participant count, control group or protocol is given, so we have not treated it as evidence. Several statistics on the approach page carry asterisks with no footnote anywhere on the page.

Finally, on the point of law that runs through this review: a dietary supplement cannot legally be marketed as preventing a disease, and a urinary tract infection is a disease. Good Kitty describes the product as clinically proven UTI prevention and as preventing UTIs before they start, on pages that carry the standard disclaimer saying the product is not intended to diagnose, treat, cure or prevent any disease. We are describing what the pages say. We are not regulators and this is not a legal determination.

Frequently Asked Questions

Verdict

We wanted to like this. The cranberry dose is correct, the education content is better than most publishers manage, the safety pages address warfarin and oxalates with a specificity we almost never see, and the company tells people with an active infection to go get antibiotics. Those are not small things.

But the headline efficacy number on the research page is credited by name to a trial that did not find it, the FDA claim is displayed with the sentence about limited evidence removed, the phrase versus placebo is attached to two trials that had no placebo arm, and the second active ingredient sits at a quarter of a dose that itself failed when it was finally tested properly. Any one of those could be carelessness. Together, on a site that elsewhere writes about oxalate content to two decimal places, they look like editing.

If you buy it, buy the one-off Starter Kit rather than subscribing, because the guarantee covers the first order and nothing after it. Decide inside 30 days. If you do subscribe, set the delivery interval to 60 days unless you are taking two capsules daily, which halves the annual cost. And have the conversation with a clinician first, because the two interventions with the strongest evidence for recurrent UTI are both prescriptions, and the third is water.